XML 114 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Debt Obligations (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt and Finance Lease Obligations
Debt obligations, including finance lease obligations, consisted of the following (in millions):
December 31,
Infrastructure
20242023
PRIME minus 0.75% Line of Credit due 2025
$45.0 $100.0 
3.25% Term Loan due 2026
74.6 91.4 
PRIME minus 0.75% Term Loan due 2026
24.5 — 
4.00% Note due 2024
— 5.0 
Obligations under finance leases0.6 2.4 
Total Infrastructure$144.7 $198.8 
Spectrum
8.50% Note due 2025
$19.3 $19.3 
11.45% Notes due 2025
50.4 50.4 
Total Spectrum$69.7 $69.7 
Life Sciences
20.00% Notes due 2025
$24.0 17.4 
Total Life Sciences$24.0 $17.4 
Non-Operating Corporate
   8.50% Senior Secured Notes due 2026
$330.0 $330.0 
7.50% Convertible Senior Notes due 2026
48.9 51.8 
SOFR plus 5.75% Line of Credit due 2025
20.0 20.0 
CGIC Unsecured Note due 202631.0 35.1 
Total Non-Operating Corporate$429.9 $436.9 
Total outstanding principal$668.3 $722.8 
Unamortized issuance discount, issuance premium, and deferred financing costs(5.5)(13.0)
Less: current portion of debt obligations(162.2)(30.5)
Debt obligations, net of current portion$500.6 $679.3 
Schedule of Maturities of Debt and Finance Lease Obligations
As of December 31, 2024, estimated future aggregate finance lease and debt payments, including interest, were as follows (in millions):

Finance LeasesDebtTotal
2025(1)(2)
$0.3 $238.7 $239.0 
20260.2 508.4 508.6 
20270.1 — 0.1 
Total minimum principal and interest payments
0.6 747.1 747.7 
Less: Amount representing interest (1)(2)
— (79.4)(79.4)
Total aggregate finance lease and debt payments $0.6 $667.7 $668.3 
(1) Excludes exit fees for Spectrum and R2 Technologies.
(2) Excludes additional estimated interest payments of $0.4 million resulting from the extension subsequent to year end of the Non-Operating Corporate SOFR plus 5.75% Line of Credit from May 16, 2025, to August 1, 2025, and excludes additional estimated interest due of $2.9 million resulting from the extension subsequent to year end of the R2 Technologies 20.0% Note with Lancer Capital from December 31, 2024, to August 1, 2025.